Vir Biotechnology
VIR
11.52
-0.08
-0.69%
Vir Biotechnology
US · VIR
#2824 by market cap
Listed 2019
11.52
-0.08
-0.69%
Live - 5344 symbols - heartbeat 429s ago
· 2026-10-08 08:06
Pre-market
11.34
-1.56%
After-hours
11.52
0.00%
Overnight
11.64
+1.04%
- Market cap
- 1.95B
- P/E (TTM)i
- -6.51
- P/Bi
- 1.98
- EPSi
- -3.16
- Div yieldi
- 0.00%
- 52W posi
- 94%
Reader sentiment
Are you bullish or bearish on VIR?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 8 analysts
Buy
Avg price target
21.00 +82.3%
Price target rangecurrent 11.52
Low15.00
Avg21.00
High30.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-29 | Leerink Partners | -- | BUY | 17.00 |
| 2026-09-28 | Needham | -- | BUY | 18.00 |
| 2026-09-21 | H.C. Wainwright | -- | BUY | 20.00 |
| 2026-08-10 | H.C. Wainwright | -- | BUY | 20.00 |
| 2026-08-07 | BofA Securities | -- | BUY | 15.00 |
| 2026-08-06 | Morgan Stanley | -- | BUY | 25.00 |
| 2026-08-06 | Evercore | -- | BUY | 22.00 |
| 2026-08-06 | Needham | -- | BUY | 18.00 |
| 2026-08-06 | Leerink Partners | -- | BUY | 19.00 |
| 2026-08-06 | Barclays | -- | BUY | 30.00 |
| 2026-08-05 | TD Cowen | -- | BUY | -- |
| 2026-06-11 | Morgan Stanley | -- | BUY | 27.00 |
| 2026-06-03 | H.C. Wainwright | -- | BUY | 20.00 |
| 2026-06-01 | Barclays | -- | BUY | 30.00 |
| 2026-05-29 | BofA Securities | -- | BUY | 16.00 |
| 2026-05-28 | H.C. Wainwright | -- | BUY | 20.00 |
| 2026-05-27 | Leerink Partners | -- | BUY | -- |
| 2026-05-22 | H.C. Wainwright | -- | BUY | 20.00 |
| 2026-05-19 | H.C. Wainwright | -- | BUY | 20.00 |
| 2026-05-13 | BofA Securities | -- | BUY | 16.00 |
| 2026-05-08 | Morgan Stanley | -- | BUY | 23.00 |
| 2026-05-08 | H.C. Wainwright | -- | BUY | 20.00 |
| 2026-05-07 | TD Cowen | -- | BUY | -- |
| 2026-05-07 | BofA Securities | -- | BUY | 16.00 |
| 2026-05-07 | Evercore | -- | BUY | 18.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-05 | After close | ±13.96% | -3.79% (in line) |
| 2026/Q1 | 2026-05-06 | After close | ±13.51% | -9.91% (in line) |
| 2025/Q4 | 2026-02-23 | After close | ±26.85% | +27.73% (beat) |
| 2025/Q3 | 2025-11-05 | After close | ±26.19% | -5.19% (in line) |
| 2025/Q2 | 2025-08-06 | After close | ±11.42% | -14.37% (beat) |
| 2025/Q1 | 2025-05-07 | After close | ±18.72% | -3.57% (in line) |
| 2024/Q4 | 2025-02-26 | After close | ±24.92% | -11.85% (in line) |
| 2024/Q3 | 2024-10-31 | After close | ±14.02% | +23.63% (beat) |
| 2024/Q2 | 2024-08-01 | After close | ±15.66% | -5.34% (in line) |
| 2024/Q1 | 2024-05-02 | After close | ±19.00% | +13.18% (in line) |
| 2023/Q4 | 2024-02-22 | After close | ±21.56% | +11.94% (in line) |
| 2023/Q3 | 2023-11-02 | After close | ±20.74% | +6.96% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:06:24 · For reference only, not investment advice and not tailored to your situation.